Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald F van Vollenhoven

Showing results (1-10 of 259) with videos related to

Pageof 26
Sort By:
BMC Medicine|April 1, 2009
Sex differences in rheumatoid arthritis: more than meets the eyeRonald F van Vollenhoven
Arthritis Research & Therapy|March 18, 2008
Rheumatologists, take heart! We may be doing something rightRonald F van Vollenhoven
The New England Journal of Medicine|January 28, 2026
Educational Strategies to Prepare Trainees for Clinical UncertaintyRonald F van Vollenhoven
Presse Medicale (Paris, France : 1983)|June 1, 2016
New therapeutic approaches in rheumatoid arthritisRonald F van Vollenhoven
Current Opinion in Rheumatology|March 16, 2013
Small molecular compounds in development for rheumatoid arthritisRonald F van Vollenhoven
Arthritis & Rheumatology (Hoboken, N.J.)|November 19, 2016
Editorial: Who Gets Lupus? Clues to a Tantalizing SyndromeRonald F van Vollenhoven
Annals of the Rheumatic Diseases|June 20, 2007
Switching between anti-tumour necrosis factors: trying to get a handle on a complex issueRonald F van Vollenhoven
Annals of the Rheumatic Diseases|July 17, 2009
How to dose infliximab in rheumatoid arthritis: new data on a serious issueRonald F van Vollenhoven
Current Opinion in Rheumatology|August 7, 2013
Challenges and opportunities in SLE clinical trialsRonald F van Vollenhoven
Expert Opinion on Pharmacotherapy|January 5, 2002
Dehydroepiandrosterone for the treatment of systemic lupus erythematosusRonald F van Vollenhoven
Pageof 26

Showing results (1-10 of 259) with videos related to

Sort By:
Pageof 26
BMC Medicine|April 1, 2009
Sex differences in rheumatoid arthritis: more than meets the eyeRonald F van Vollenhoven
Arthritis Research & Therapy|March 18, 2008
Rheumatologists, take heart! We may be doing something rightRonald F van Vollenhoven
The New England Journal of Medicine|January 28, 2026
Educational Strategies to Prepare Trainees for Clinical UncertaintyRonald F van Vollenhoven
Presse Medicale (Paris, France : 1983)|June 1, 2016
New therapeutic approaches in rheumatoid arthritisRonald F van Vollenhoven
Current Opinion in Rheumatology|March 16, 2013
Small molecular compounds in development for rheumatoid arthritisRonald F van Vollenhoven
Arthritis & Rheumatology (Hoboken, N.J.)|November 19, 2016
Editorial: Who Gets Lupus? Clues to a Tantalizing SyndromeRonald F van Vollenhoven
Annals of the Rheumatic Diseases|June 20, 2007
Switching between anti-tumour necrosis factors: trying to get a handle on a complex issueRonald F van Vollenhoven
Annals of the Rheumatic Diseases|July 17, 2009
How to dose infliximab in rheumatoid arthritis: new data on a serious issueRonald F van Vollenhoven
Current Opinion in Rheumatology|August 7, 2013
Challenges and opportunities in SLE clinical trialsRonald F van Vollenhoven
Expert Opinion on Pharmacotherapy|January 5, 2002
Dehydroepiandrosterone for the treatment of systemic lupus erythematosusRonald F van Vollenhoven
Pageof 26